Research programme: mGlu7 NAM - Addex Therapeutics
Alternative Names: Metabotropic glutamate receptor 7 modulators - Addex TherapeuticsLatest Information Update: 15 Sep 2021
At a glance
- Originator Addex Therapeutics
- Class Anxiolytics; Small molecules
- Mechanism of Action Metabotropic glutamate receptor 7 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Post-traumatic stress disorders
Most Recent Events
- 01 Sep 2021 Preclinical trials in Post-traumatic stress disorders in Switzerland (PO) (Addex Therapeutics pipeline, September 2021)